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Viral membrane proteinAlthough previous work identiﬁed 12 complementation groups with possible roles in virus assembly,
currently only one frog virus 3 protein, the major capsid protein (MCP), has been linked with virion
formation. To identify other proteins required for assembly, we used an antisense morpholino
oligonucleotide to target 53R, a putative myristoylated membrane protein, and showed that treatment
resulted in marked reductions in 53R levels and a 60% drop in virus titers. Immunoﬂuorescence assays
conﬁrmed knock down and showed that 53R was found primarily within viral assembly sites, whereas
transmission electron microscopy detected fewer mature virions and, in some cells, dense granular bodies
that may represent unencapsidated DNA-protein complexes. Treatment with a myristoylation inhibitor (2-
hydroxymyristic acid) resulted in an 80% reduction in viral titers. Collectively, these data indicate that 53R is
an essential viral protein that is required for replication in vitro and suggest it plays a critical role in virion
formation..G. Chinchar).
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Viruses within the family Iridoviridae possess large double-
stranded DNA genomes enclosed within icosahedral nucleocapsids
(Chinchar et al., 2005). The family is divided into ﬁve genera, two that
infect invertebrates (Iridovirus and Chloriridovirus) and three that
infect cold-blooded vertebrates (Ranavirus, Lymphocystivirus, and
Megalocytivirus). Whereas viruses within the Megalocytivirus and
Lymphocystivirus genera infect only ﬁsh, ranaviruses cause systemic
disease in a wide range of agriculturally and ecologically important
amphibians, reptiles, and ﬁsh (Hyatt et al., 2000; Chinchar, 2002;
Williams et al., 2005; Mendelson et al., 2006; Chinchar et al., 2009).
Members of the genus Ranavirus are responsible for die-offs of farm
raised frogs in China, Thailand, and North and South America,
salamanders in western North America, and multiple ﬁsh species
worldwide (Nakajima et al., 1998; Green et al., 2002; Whittington
et al., 1996; Ariel et al., 1999).Frog virus 3 (FV3) is the type species of the genus Ranavirus and
the best characterized member of the family. Study of FV3 has
illuminated many, if not most, of the key elements of iridovirus
replication including the temporal regulation of viral gene expression,
nuclear and cytoplasmic phases of infection, and transcriptional and
translational control mechanisms (reviewed in Chinchar et al., 2009).
Although sequence analysis of the FV3 genome identiﬁed 98 ORFs, the
functions of only about a third of these genes, based on biochemical
studies or BLAST analysis, are known or inferred (Tan et al., 2004;
Eaton et al., 2007). The remaining genes fall into two categories: the
majority shows homology to other iridovirus genes, but not to others
in the database, whereas a smaller number are unique to the viruses
encoding them. We postulate that these genes may play speciﬁc roles
in viral metabolism and/or virion assembly or allow a virus to
replicate in a speciﬁc host by inhibiting innate and acquired
immunity.
Until recently, attempts at elucidating FV3 gene function have
relied on classical biochemical and genetic approaches. For example,
Chinchar and Granoff (1986) characterized 28 temperature sensitive
mutants and ordered them into 19 complementation groups and four
phenotypic classes. Mutants within classes II–IV played various roles
Fig. 1. SDS–PAGE analysis of asMO-treated, FV3-infected FHM cells. Mock-infected
(lane 1) and virus-infected FHM cells (lanes 2–6) were exposed to the indicated asMOs
(lanes 3–5) or treated with 1 mM 2-hydroxymyrisitic acid (lane 6) and protein
synthesis monitored 7–9 hours p.i. Radiolabeled proteins were separated on a 10% SDS–
PAGE and visualized by phosphorimaging. The position of the MCP is indicated by an
arrow. Molecular weight markers (kDa) are shown to the left of the gel image. Lane
headings here and elsewhere refer to untreated, FV3-infected FHM cells (FV3), or FV3-
infected cells pretreated with a nontargeting control MO (CTL), an asMO targeted to the
major capsid protein (MCP), an asMO targeted against 53R (53R), or 2-hydroxymyristic
acid (MyrA).
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role primarily in virion assembly. However, expansion of these studies
has been hindered by the difﬁculty of using site-directed mutagenesis
or gene knockout via homologous recombination to generate speciﬁc
viral mutants. To circumvent these problems, we and others
examined the function of ranavirus gene products using either
antisense morpholino oligonucleotides (asMOs) or siRNAs to knock
down the expression of speciﬁc viral gene products and infer gene
function by changes in phenotype (Sample et al., 2007; Xie et al.,
2005; Dang et al., 2008). Speciﬁcally, we have used asMOs to
knockdown the expression of the FV3 major capsid protein (MCP)
and a viral homolog of the largest subunit of RNA polymerase II (vPol-
IIα). Those studies conﬁrmed that the MCP was required for virion
assembly, whereas the vPol-IIα was essential for the expression of
late gene products (Sample et al., 2007). We also showed that a highly
abundant 18 kDa immediate early protein was nonessential for
replication of FV3 in FHM cells in vitro (Sample et al., 2007). Here
we seek to elucidate the function of a putative viral myristoylated
membrane protein, 53R, using an asMO-mediated approach.
FV3 virions share structural features with other nuclear cytoplas-
mic large DNA viruses (NCLDVs) that possess icosahedral symmetry
such as African swine fever virus (ASFV) and the phycodnaviruses that
infect algae (Iyer et al., 2006; Wilson et al., 2009; Tulman et al., 2009).
FV3 virions are ∼150 nm in diameter and composed of four major
structural components that, from inside-out, include a central DNA–
protein core, an internal lipid membrane, an icosahedral capsid, and,
in the case of virus released by budding from the plasmamembrane, a
viral envelope (Williams et al., 2005; Chinchar et al., 2009). ASFV and
FV3 virion assembly occurs in morphologically distinct regions within
the cytoplasm (i.e., viral factories/assembly sites, respectively) that
contain both viral DNA and protein (Chinchar et al., 1984a,b; Wilson
et al., 2009). In the ASFV system, cellular membranes, likely derived
from the endoplasmic reticulum, are required for the formation of
infectious virions and serve as the source of the internal lipid
membrane that lies between the DNA core and the outer capsid
shell (Cobbold et al., 1996; Rouiller et al., 1998). Moreover, there is
evidence that an ASFV-encoded protein (p54) mediates the recruit-
ment and utilization of these membranes (Rodriguez et al., 2004).
Myristoylated viral proteins have been shown to be required for
the assembly of many viruses including human immunodeﬁciency
virus 1 (HIV-1), arenaviruses, ASFV, vaccinia virus, and others
(Göttlinger et al., 1989; Bryant and Ratner, 1990; Martin et al., 1997,
1999; Capul et al., 2007; Andrés et al., 2002a). These proteins associate
with cellular membranes through hydrophobic myristoyl groups that
allow them to embedwithin lipid bilayers (Maurer-Stroh et al., 2002).
Myristoylation is dependent upon a conserved amino acid motif at the
N-terminus of the protein, NH2-M-G-X-X-X-(S/T/A) (Farazi et al.,
2001). In the presence of this sequence, N-myristoyltransferase
catalyzes the addition of myristate, a 14-carbon saturated fatty acid,
to the penultimate G residue. In the case of ASFV, a precursor protein
with a myristoylation motif, pp220, associates with cellular mem-
branes and is required for virion assembly.
Like pp220 of ASFV, FV3 ORF 53R encodes a protein with an N-
terminal myristoylation sequence that possibly plays an essential role
in virion assembly (Tan et al., 2004). 53R is a highly conserved, virion-
associated protein that is present in all ﬁve genera within the family
Iridoviridae (Eaton et al., 2007; Zhao et al., 2008). Because of their
putative myristoylation sequences, we postulate that FV3 ORF 53R
and pp220 perform similar roles in virion assembly. To explore that
possibility, we inhibited 53R protein expression using asMOs and
determined the effect of knock down on virus replication and
assembly. We showed that knockdown of ORF 53R had no effect on
overall viral gene expression, but resulted in a decrease in virion
formation and a reduction in the formation of mature virions. These
results indicate that 53R, perhaps in a manner analogous to pp220,
plays a key role in FV3 virion biogenesis.Results
Knock down of ORF 53R expression
To determine the role of 53R, a putative 54.7-kDa myristoylated
membrane protein, in FV3 biogenesis, we blocked its expression using
asMOs and ascertained the effect of knock down on viral gene
expression and virion formation. FHM cells were pretreated for
24 hours with an asMO targeted to the message for 53R. In addition,
FHM cells were pretreated with a nonsilencing control asMO or one
targeting theMCP as negative and positive controls, respectively. FHM
cells were subsequently infected with FV3, and protein synthesis
monitored by radiolabeling infected cells from 7 to 9 hours p.i. and
analyzing host and viral protein synthesis by SDS–PAGE. As shown in
Fig. 1, FV3 infection resulted in a marked inhibition of host cell protein
synthesis (compare lane 1, mock-infected cells to lane 2, FV3-infected
cells) and the appearance of at least 15 novel bands that likely
represent FV3-speciﬁc proteins. Treatment of infected cells with
either a nontargeting control MO or an inhibitor of myristoylation
(see below) had no apparent effect on viral protein synthesis.
However, as seen earlier, treatment with an asMO targeting the
MCP resulted in a marked reduction in the synthesis of the MCP,
without adversely affecting the synthesis of other viral proteins. In
contrast, treatment with an asMO targeting 53R had no effect on the
overall expression of viral proteins, and no reduction in a band of the
expected size (∼54 kDa) was observed. While this result could reﬂect
the inability of this asMO to effectively knock down 53R synthesis, it
could also be due to the presence of limiting amounts of 53R and/or
the comigration of 53R with the more abundant MCP.
To resolve this issue, we obtained a plasmid expressing the 53R
gene of Rana gyrlio virus (RGV), a ranavirus that is likely a strain of FV3
(Zhang et al., 2001; Zhao et al., 2008), and used this recombinant
protein to develop polyclonal rabbit anti-53R serum. Using rabbit
polyclonal anti-53R serumwe demonstrated (Fig. 2) that 53R was not
Fig. 2. Western blot analysis of asMO-treated, FV3-infected FHM cells. Mock-infected
(lane 1) and FV3-infected FHM cells (lanes 2–5) were untreated (lane 2) or pretreated
for 24 hours with a nontargeting control MO (CTL; lane 3), or asMOs targeted against
the MCP (lane 4) or 53R (lane 5). At 9 hours p.i., lysates were prepared, and proteins
were separated by SDS–PAGE and transferred to a nitrocellulose membrane. The
membrane was incubated with rabbit anti-53R serum for 2 hours followed by
incubation with HRP-conjugated goat anti-rabbit antibody. Proteins were visualized
using a chemiluminescent substrate. Molecular weight markers are shown to the left of
the ﬁgure.
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lysates as a single band that comigrated at ∼50 kDa along with the
MCP (compare Figs. 1 and 2, lane 2). Consistent with an earlier study,
there was a slight decrease in 53R levels when an asMO targeting the
MCP or a nontargeting control MO were used. This reduction was
likely due to the transfection reagent since we previously observed a
similar global decrease in viral protein synthesis when EndoPorter
was used alone (Sample et al., 2007). However, in contrast to this
modest level of inhibition, prior treatment with an asMO targeting
53R markedly reduced 53R levels (Fig. 2, lane 5). Furthermore, the
observed co-migration of MCP and 53R suggests that our earlier
inability to detect 53R knock down by 1D SDS-PAGE was due to the
presence of abundant levels of MCP that obscured detection of 53R. In
addition, the observation that MCP expression is nearly completely
blocked by asMO knock down (Fig. 1, lane 4) suggests that if MCP and
53R are present within the same region of the gel, MCP represents the
bulk of the material, whereas 53R is a minor component.
To conﬁrm this result and determine the intracellular location of
53R, we used anti-53R serum to demonstrate asMO-mediated knock
down by indirect immunoﬂuorescence assay (IFA). FHM cells were
either mock-infected or infected with FV3 and at 24 hours p.i., were
ﬁxed, sequentially incubated with polyclonal anti-53R serum and
FITC-conjugated goat anti-rabbit serum, and stained with Hoechst
33258. As expected, 53R-speciﬁc ﬂuorescence was not detected in
mock-infected cells (Fig. 3, A) whereas marked ﬂuorescence was seen
within viral assembly sites in both untreated cells (data not shown)
and cells treated with a nontargeting control MO (Fig. 3D). Consistent
with theWestern blot ﬁndings, treatmentwith an asMO targeting 53R
resulted in the almost complete absence of 53R staining within FV3-
infected cells (Fig. 3G). In addition, we observed that mock-infected
cells stained with Hoechst displayed well-formed nuclei, but that
following virus infection, nuclei show marked alterations in appear-
ance (Fig.3, compare B and E). Furthermore, small Hoechst-stained
bodies appear adjacent to the nuclei and likely represent viral
assembly sites. As shown in Fig. 3H, assembly sites persist after
treatment with the anti-53R asMO indicating that wild-type levels of
53R are not needed for assembly site formation. Collectively, the
results shown in Figs. 2 and 3 conﬁrm that treatment with an asMO
targeted against 53R resulted in a marked reduction in its synthesis.
In a previous study, we noted that a greater than 80% reduction in
the synthesis of the 18K immediate early protein had no effect on the
expression of other viral genes or the yield of infectious virus and
indicated that 18K was nonessential for replication in vitro (Sampleet al., 2007). To determine if 53R was essential for virus replication,
we analyzed viral yields in cells treated with the anti-53R asMO. As
shown in Fig. 4, treatment of FV3-infected FHMs with anti-53R asMO
reduced viral titers by more than 60% and TEM analysis indicated a
corresponding reduction in mature virions (Fig. 5). Most anti-53R
asMO-treated, FV3-infected cells displayed viral assembly sites, but
showed marked reductions in the number of mature virions (Fig. 5,
compare A and B). However, aggregates, possibly representing viral
protein–DNA complexes, could be observed in some 53R asMO-
treated cells (Fig. 5C and D). The appearance of these structures was
possibly due to a block in virion assembly due to limiting amounts of
53R protein. Collectively, these ﬁndings showed that like the MCP,
53R was essential for virus replication in vitro.
Role of myristoylation in FV3 virion morphogenesis
The above studies demonstrate that 53R is required for FV3
replication and virion assembly. However, these studies do not
formally prove that 53R is myristoylated or that myristoylation is
important in viral replication. To address these questions, we ﬁrst
asked what effect inhibition of myristoylation had on FV3 replication.
Replicate FHM cells were treated with 1 mM 2-hydroxymyristic acid
(myrA), an inhibitor of myristoylation, 1 hour before and continu-
ously throughout infection, and viral protein synthesis wasmonitored
by radiolabeling with [35S]methionine from 7 to 9 hours p.i. SDS–
PAGE analysis showed no difference between treated and untreated
cells indicating that the inhibitor did not affect primary viral gene
expression (Fig. 1, lane 6). Although myrA treatment had no effect on
viral protein synthesis, we asked what effect myrA treatment had on
virus replication by monitoring viral yields in control and myrA-
treated cells. Consistent with other viral systems in whichmyristoyla-
tion was shown to be important for virus replication, treatment of
FV3-infected cells with 1 mM myrA resulted in an 80% reduction in
viral yields (Fig. 4). Furthermore, TEM analysis of myrA-treated FV3-
infected cells showed a marked reduction in virion formation and the
appearance of numerous empty virions (Fig. 6B–D).
To determine if myrA affected the intracellular localization of 53R,
virus-infected cells treated with myrA were examined by IFA
following incubation with anti-53R antibody and staining with
Hoechst 33258 (Fig. 3J, K, and L). As seen previously, FV3 infection
affected nuclear morphology and resulted in the appearance of lightly
staining perinuclear bodies that likely represent viral assembly sites
(Fig. 3H). However, even in the presence of myrA, assembly sites were
stained by an antibody targeting 53R (Fig. 3J), suggesting that the lack
of myristoylation did not grossly affect the intracellular localization of
53R.
Discussion
The abovementioned results indicate that FV3 ORF 53R, a putative
myristoylated membrane protein, was required for a productive FV3
infection in vitro. Herein we showed that blocking 53R expression
using a gene-speciﬁc asMO resulted in a marked reduction in 53R
protein expression and an ∼60% drop in viral titers. The reduction in
the level of mature virions suggests that 53R, in a manner analogous
to some myristoylated viral proteins, is required for virion assembly.
Moreover, asMO-mediated repression of 53R expression was gene
speciﬁc and did not affect the synthesis of other viral proteins or block
the formation of viral assembly sites. Furthermore, whereas TEM
analysis showed that in most cells fewer mature virions were present,
in a minority of cells dense granular bodies (DGB) were detected
within viral assembly sites. DGBs may represent protein–DNA
complexes that were not encapsidated, or viral structural proteins
that aggregated and were not capable of forming mature capsids in
the absence of normal levels of 53R. While the precise composition of
DGBs is unknown, similar structures were observed following
Fig. 3. Intracellular localization of FV3 53R by indirect immunoﬂuoresence microscopy. FHM cells were mock-infected (A–C), or FV3 infected following treatment with a
nontargeting control asMO (D–F), an anti-53R asMO (G–I), or myrA (J–L) as described in Materials and methods. Twenty-four hours after infection, the cells were ﬁxed,
permeabilized, and incubated with rabbit anti-53R serum and FITC-conjugated anti-rabbit antibody, followed by staining with Hoescht 33258.
Fig. 4. FV3 yields following treatment with anti-53R asMO and myrA. FHM cells were
treated with anti-53R asMO 24 h before FV3 infection or treated with 1 mM 2-
hydroxymyristic acid 1 h before and continuously throughout FV3 infection. At
24 hours p.i., replication was stopped by freezing and viral yields determined by
plaque assay. Shown are the averages and standard deviations of seven replicates from
anti-53R-treated cultures and four replicates from myrA-treated cells.
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ed at nonpermissive temperatures (Chinchar and Granoff, 1986, RC
Sample and VG Chinchar, unpublished observations) and in wt-
infected cells shifted to 37 °C after initial growth at permissive
temperatures (Tripier et al., 1977). Collectively, these results support
the importance of 53R in virion assembly.
N-myristoylation is an irreversible protein modiﬁcation that occurs
co-translationally in eukaryotes and their viruses andpromotesweak and
reversible protein–membrane and protein–protein interactions (Farazi
et al., 2001). Although myristoylation is required for the replication of
retroviruses (Göttlinger et al., 1989), poxviruses (Ravanello et al., 1993;
Ravanello and Hruby, 1994a, 1994b), herpesviruses (Harper et al., 1993),
arenaviruses (Perez et al., 2004), geminiviruses (Fondong et al., 2007),
picornaviruses (Goodwin et al., 2009), and reoviruses (Chandran et al.,
2002), viruses, with the likely exception of entomopoxvirus, do not
encode myristoyltransferases, but rely on cellular enzymes. Myristoyla-
tion occurs on the penultimate G residue of proteins bearing the
consensus sequence (NH2-M-G-(X)3-[S/T/A]-COOH) and may play a
role in either virion assembly, virion entry or both. Several examples
illustrate this point. In vaccinia virus, sixmyristoylated viral proteins have
been identiﬁed and three (L1R, A16L, andE7R)havebeencharacterized in
detail (Martin et al., 1997). A16L and E7R are soluble proteins, whereas
L1R is membrane associated. Analysis of conditional lethal mutants
demonstrated that L1R is an integral component of the membranes of
Fig. 5. Transmission electron microscopy of control and anti-53R asMO-treated, FV3-infected FHM cells. FHM cells were treated with CTL or anti-53R asMOs and 24 hours later
infected with FV3 (MOI=20 PFU/cell). At 9 hours p.i., cultures were ﬁxed in 2% glutaraldehyde and processed for electron microscopy. (A) Control asMO-treated, FV3-infected FHM
cells. (B–D) Anti-53R asMO-treated, FV3-infected FHM cells. Panel D is an enlargement of the cell shown in panel C. N, nucleus; AS, assembly site; closed arrowheads indicate mature
virions; open arrowhead indicate dense granular bodies; arrow indicates a paracrystalline array. Scale bars represent 1.5 μm.
452 D.S. Whitley et al. / Virology 405 (2010) 448–456intracellular mature virions and is essential for virion morphogenesis
(Ravanello and Hruby, 1994a,b). In nonenveloped, RNA-containing
icosahedral viruses such as poliovirus and foot-and-mouth disease virusFig. 6. Transmission electron microscopy of myrA-treated, FV3-infected cells. (A) Nontrea
9 hours p.i., cells were processed for transmission electron microscopy as indicated in Mater
closed arrowheads indicate virions; open arrowheads indicate empty capsids. Scale bars re(family Picornaviridae) and reovirus (family Reoviridae) myristoylation is
thought to be required both for virion assembly (Goodwin et al., 2009)
andvirus entry (Chandranet al., 2002; Belnap et al., 2000).Myristoylationted, FV3-infected FHM cells. (B–D) MyrA-treated (1 mM), FV3-infected FHM cells. At
ials and methods. N, nucleus; AS, assembly site; arrow indicates a paracrystalline array;
present 1.5 μm.
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virion assembly by stabilizing the ﬁve protomeric subunits that form the
pentameric vertices (Chow et al., 1987;Marc et al., 1990, 1991), Likewise,
externalization of N-myristoylated VP4 exposes amphipathic sequences
within VP1 that may mediate entry (Belnap et al., 2000).
Assembly mechanisms, more relevant to the study of FV3 than
those cited above, are provided by the ASFV model. ASFV is a large,
icosahedral dsDNA-containing virus that is phylogenetically related to
poxviruses, iridoviruses, phycodnaviruses, mimiviruses, and ascov-
iruses (Iyer et al., 2006; Wilson et al., 2009). ASFV has been described
as a “poxvirus in iridovirus clothing” in reference to its poxvirus-like
genomic organization and iridovirus-like virion morphology (Tulman
et al., 2009). Like FV3, ASFV formation takes place within perinuclear
cytoplasmic viral factories or assembly sites (AS) that bear a striking
resemblance to aggresomes. ASFV viral factories and aggresomes (and
likely FV3 AS) are located close to the microtubule-organizing center,
exclude cellular organelles, recruit chaperones and mitochondria, and
are surrounded by the vimentin network (Heath et al., 2001; Murti
and Goorha, 1989; Murti et al., 1985). ASFV recruits cellular
membranes that are likely derived from the endoplasmic reticulum
(ER) or Golgi to viral factories where virion formation takes place
(Rodriguez et al., 2004). Viral assembly is thought to involve the
deposition of capsid protein (p72) and pB438L on the convex surface
of the membrane and pp220 and pp62 onto the concave surface
(Andrés et al., 1997, 2002a,b; Suárez et al., 2010). pp220 is a
myristoylated polyprotein that gives rise to four virion-associated
cleavage products (p150, p37, p34, and p14), whereas pp62 is a
polyprotein that is cleaved to generate p35 and p14. Together pp220
and pp62 and their cleavage products make up about one-third of
virion mass and form the “core shell” that lies between the internal
lipid membrane and the DNA core. Although pp220 is thought to
interact with lipid membranes through its myristoyl group, pp220 is
not needed for the formation of virus-like particles since in its absence
p72 associates with membranes and leads to the formation of empty
capsids (Andrés et al., 2002a). In addition to pp220, ASFV also encodes
at least one other myristoylated protein, pE248R that is required for
viral infectivity (Rodríguez et al., 2009). Like pp220, pE248R
associates with the membrane fraction in infected cells, but it appears
to function at the level of virion entry, rather than in virion assembly.
pE248R belongs to a class of myristoylated membrane proteins
related to the vaccinia virus L1R protein. These proteins contain
disulﬁde bridges and, at least in the case of pE248R, are thought to be a
ﬁnal substrate for virus-encoded redox enzymes such as the ﬂavin
adenine dinucleotide-linked sulfhydryl oxidase encoded by pB119L
(Rodríguez et al., 2006).
To identify possible homologs of FV3 53R, PSI-BLAST analysis was
conducted using 53R as the query (Altschul et al., 1997). Aside from
the expected identiﬁcation of conserved iridovirus proteins, PSI-
BLAST showed signiﬁcant homology to at least two ascovirus proteins
and the ASFV pE248R protein (E value 2e-37) but did not detect
homology to pp220 or any of its cleavage products. Since inspection of
the FV3 genomic sequence (Tan et al., 2004) identiﬁed no other ORFs
containing the consensusmyristoylation sequence, it is likely that 53R
is the only candidate for myristoylation among the FV3 proteome.
Whether 53R functions like pE248R or pp220 remains to be resolved.
FV3 53R (522 amino acids) is more than twice the size of either
vaccinia L1R (250 amino acids) or ASFV pE248R (248 amino acids)
and sequence similarity among these three proteins is very low (10–
11%). Currently, we do not know if FV3 53R functions at entry, like
pE248R, during assembly, like pp220, or in both capacities. The
observation that virion assembly is diminished in anti-53R asMO-
treated cells suggests a role similar to pp220, whereas the PSI-BLAST
result showing homology with pE248R supports a role in entry.
At present, the composition of the FV3 core shell is unknown.
Although IFA indicates that 53R is present within FV3 AS, we do not
know its precise location. However, using rabbit anti-53R serum, weshould be able to determine by immunoelectron microscopy whether
53R is associated with membranous structures, virion intermediates,
or virions. Preliminary coimmunoprecipitation data suggest that 53R
associated with at least one other viral protein, possibly the MCP. If
that result is conﬁrmed, it may suggest that 53R and MCP are closely
associated, perhaps bound to the same membrane fragment.
However, it would not distinguish between independent binding of
MCP and 53R to the membrane, or whether prior binding of 53R is
required for subsequent binding by the MCP.
A recent study by Zhao et al. (2008) showed that 53R preferen-
tially associated with viral AS in cells infected with Rana grylio virus,
an isolate that is likely a strain of FV3 (Zhang et al., 2001). Multiple
alignment indicated that RGV 53R was N99% identical to FV3 53R and
that among divergent rana-, megalocyti-, irido-, chlorirido-, and
lymphocystiviruses regions of identity, including two conserved
cysteines, were present. Treatment of RGV virions with NP-40 plus/
minus dithiothreitol resulted in the appearance of 53R in the soluble
fraction suggesting that 53R was membrane associated. However, it is
not clear from these results whether 53R was associated with the
internal lipid membrane or the external viral envelope.
As indicated above, among the 98 putative FV3 ORFs, only ORF 53R
possesses an N-terminal myristoylation motif and is thus the only
candidate for myristoylation. To formally demonstrate myristoylation
of 53R, studies are in progress using 3H-myristic acid to label, and
polyclonal rabbit anti-53R serum to immunoprecipitate 53R and
speciﬁcally detect the myristoylated protein. Moreover, we have
obtained evidence consistent with this view by demonstrating that
treatment with myrA markedly reduced FV3 replication and resulted
in an almost complete inhibition of virion formation. The observed
reduction in virus yields was not a consequence of the toxicity of the
compound since growth of FHM cells in myrA for 48 hours had no
observable effect on host cell viability (data not shown). In addition,
viral protein synthesis was neither quantitatively nor qualitatively
altered in myrA-treated cells (Fig. 1). Moreover, although the
myristoyl group is likely required for membrane association, its
presence was not required for targeting 53R to assembly sites since
blocking myristoylation did not affect the subcellular location of 53R.
Finally, as suggestive as these results are, it is possible that
myristoylation affects some other process required for virus replica-
tion. Formal proof that myristoylation of 53R is required for viral
infection will require the generation of a nonmyristoylatable mutant
as was done previously with the p220 protein of ASFV (Andrés et al.,
1997).
Taken together, our ﬁndings provide evidence that both myr-
istoylation and a putative myristoylated membrane protein were
required for a productive FV3 infection. These studies will help to
further illuminate the ranavirus assembly process and better
understand the interplay that occurs between host and virus during
productive infections. Additional characterization of the 53R protein
will be required in order to determine its exact role during FV3
infection. Coimmunoprecipitation experiments are in progress to
identify viral or host proteins that may interact with 53R. In addition,
immunoelectron microscopy will determine which cellular orga-
nelles, if any, interact with 53R. Successfully completed, these studies
will indicate whether the assembly of iridovirus virions is similar to
that of ASFV, or whether iridoviruses possess unique features that
distinguish them from their closest relatives.
Materials and methods
Cells and virus
FV3 infections were performed in fathead minnow cells (FHM,
ATCC No. CCL-42) grown in Dulbecco's modiﬁed Eagle's medium
(DMEM) containing 4% fetal bovine serum (D4) at 26 °C in a
humidiﬁed incubator in 95% air and 5% CO2. FV3 (Granoff et al.,
454 D.S. Whitley et al. / Virology 405 (2010) 448–4561966; ATCC VR-569)was propagated on conﬂuentmonolayers of FHM
cells grown in 150-cm2 ﬂasks and incubated in Eagle's minimum
essential medium with Hank's salts (HMEM) supplemented with 4%
fetal bovine serum (H4). To generate virus stocks, FHM cells were
infected at an MOI=0.01 PFU/cell and harvested ∼5 days later when
cytopathic effect was marked. Virions were released by three freeze–
thaw cycles and clariﬁed by low-speed centrifugation. Titers were
determined by plaque assay on FHM monolayers under an overlay of
0.75% methylcellulose.
Antisense morpholino oligonucleotides
AsMOs and delivery agents were purchased from GeneTools
(Philomath, OR) and were used according to the manufacturer's
protocol. Three different morpholino oligonucleotides (MO) were
utilized: a nontargeting negative control (CTL) (5′CCTCTTACCTCAGT-
TACAATTTATA3′), an asMO targeting the major capsid protein (MCP)
(5′TGAACCAGTTACAGAAGACATTTCC3′) as a positive control, and an
asMO targeting ORF 53R (53R) (5′TGTTTGATAGATTCCGCTGCTC-
CAT3′). As indicated by underlining and boldface type, both anti-
MCP and anti-53R bound slightly upstream of, or precisely at, the AUG
initiation codon. AsMOs were used at a ﬁnal concentration of 10 μM
and the delivery agent EndoPorter (EP) was used at ﬁnal concentra-
tion of 6 μM.
FV3 protein synthesis
FHMcells were grown to∼80% conﬂuency (∼1.9×106 cells/well) in
six-well tissue culture plates. On the day of assay, the media was
removed by aspiration and replacedwith 1 mLof D4. Subsequently, 6 μL
of EndoPorter and 10 μL of a 1 mM stock of the indicated asMO were
added, and the cultures incubated at 26 °C. Twenty-four hours after
treatment, the cultures were infected with FV3 at a MOI=20 PFU/cell.
To detect viral proteins, replicate cultures were radiolabeled with
methionine–cysteine free Eagle's minimum essential medium with
Earle's salts (EMEM) containing 30 μCi/mL [35S]methionine–cysteine
(EasyTag Express Protein LabelingMix, Perkin-Elmer) from 7 to 9 hours
p.i. At 9 hours p.i., the radiolabeled medium was removed, and cell
lysates were prepared by disrupting the cells in 120 μL direct sample
buffer (125 mM Tris–HCl, pH 6.8, 10% glycerol, 2% SDS, 0.02% 2-
mercaptoethanol, 0.01% bromophenol blue). Radiolabeled proteins
were separated by electrophoresis on 10% SDS–polyacrylamide gels
(Laemmli, 1970) and visualized by autoradiography using either Kodak
XAR ﬁlm or a phosphorimager (BioRad, Personal Molecular Imager).
FV3 viral yields
To determine virus yields, 80% conﬂuent FHM monolayers were
treatedwith gene-speciﬁc asMOs as previously described and infected
with FV3 at a MOI of 20 PFU/cell. Twenty-four hours after infection,
viral growth was stopped by freezing the cultures, and virions,
released by three cycles of freeze–thaw, were clariﬁed by low-speed
centrifugation. Virus-containing supernatants were serially diluted
10-fold, and 200 μL of each dilution was added to duplicate wells of
conﬂuent FHM monolayers grown on six-well plates. After a 1-hour
absorption period, the cells were overlaid with 2 mL of DMEM
containing 0.75% methyl cellulose. After 7 days, the overlay was
removed, and plaques were visualized by staining with 1% crystal
violet in 70% ethanol.
Transmission electron microscopy
Replicate cultures were treated with asMOs as previously
described and infected at a MOI=20 PFU/cell. At 9 hours p.i., the
medium was removed and the cells were rinsed gently with 0.1 M
sodium phosphate, pH 7.4. The cells were scraped into fresh buffer,pelleted, ﬁxed in 2% glutaraldehyde in 0.1 M sodiumphosphate buffer,
and stored at 4 °C until processed for electron microscopy. At that
time, the samples were postﬁxed in 1% osmium tetroxide and stained
with 2% uranyl acetate in deionized water. The samples were
dehydrated in a stepwise fashion in ethanol, the ethanol was removed
by treatment with 100% propylene oxide, and the samples were
embedded in 100% Epon. Thin sections (0.1 μm) were ﬂoated onto
200-mesh copper hexagonal grids (Electron Microscopy Science, Fort
Washington, PA), counterstained with lead citrate, and examined
using a Leo 906 (Zeiss) transmission electron microscope.Inhibition of myristoylation
FHM cells were grown to conﬂuency (∼2.4×106 cells/well) in six-
well tissue culture plates. One hour before FV3 infection, the medium
was removed by aspiration and replaced with D4 containing 1 mM 2-
hydroxymyristic acid (myrA, Sigma Chemical, cat. no. H6771), a
potent inhibitor of myristoylation (Nadler et al., 1993). Subsequently,
both control and experimental samples were infected with FV3 at an
MOI=20 PFU/cell. After a 1-hour attachment period, the inoculum
was removed and replaced with 2 mL D4 or D4 with 1 mM myrA.
Replicate cultures were processed for SDS–PAGE analysis, plaque
assay, and transmission electron microscopy as indicated above. To
maintain inhibition, treated samples were continuously in the
presence of myrA from 1 hour before infection until the termination
of the experiment.Prokaryotic expression, protein puriﬁcation, and antibody preparation
A plasmid, pET32a/53R, expressing the 53R protein from Rana gyrlio
virus was obtained from Zhao et al. (2008) and used to transform BL21
competent Escherichia coli. Transformed bacteria were treated with
0.8 mM IPTG for 4 hours at 37 °C to induce expression of recombinant
53R protein. Recombinant 53R, with an N-terminal polyhistidine tag,
was harvested using MagneHis Ni-Particles (Invitrogen) according to
the manufacturer's protocol. For the initial immunization, recombinant
53R (133 μg) was mixed with an equal volume of Freund's complete
adjuvant and used to subcutaneously immunize a rabbit. Subsequent
immunizations were repeated at 14-day intervals using 53R (66 μg)
mixed with an equal volume Freund's incomplete adjuvant. Serumwas
collected biweekly to monitor seroconversion, and a week after the 3rd
immunization, the animal was exsanguinated and serumwas prepared.
Antibody titers were determined by ELISA using puriﬁed recombinant
53R as antigen.Western blot
FHM cells were infected with FV3 at an MOI=20 PFU/cell. At
9 hours p.i., the cells were lysed in direct sample buffer and host and
viral proteins, separated by electrophoresis on a 12% SDS-polyacryl-
amide gel, were transferred to a nitrocellulose membrane at 100 V for
1 hour at 4 °C. After blocking in Tris-buffered saline (50 mM Tris–HCl,
pH 8.0, 150 mMNaCl) containing 0.01% Tween (TBST) and 10%milk at
4 °C, the membrane was incubated with anti-53R serum, diluted
1:1000 (vol./vol.) in TBST-10% milk, for 2 hours at 4 °C with agitation.
Subsequently, the primary antibody was removed; the membrane
was washed three times with TBST and incubated with horseradish
peroxidase conjugated goat anti-rabbit IgG (H+L) antibody (1:2000
dilution, Southern Biotechnology Associates, Inc., cat. no. 4050-05) for
an additional 2 hours at 4 °C. After washing, immunoreactive bands
were visualized with a SuperSignal West Pico chemiluminescent
substrate kit (Pierce Biotechnology) using the ChemiDoc XRS system
(BioRad). Mock-infected FHM cell lysates were used as negative
control.
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FHM cells were grown to ∼80% conﬂuency on poly-L-lysine-
treated microscope slides. Replicate cultures were either untreated or
treated with a control asMO or one targeting 53R for 24 hours before
infection. Cells were infected with FV3 at a MOI=20PFU/cell and a
subset of samples incubated in D4 containing 1 mM myrA for 1 hour
before, and continuously throughout, infection. At 24 hours p.i., the
cells were brieﬂy washed with PBS and ﬁxed by submersion in 3.7%
formaldehyde for 1 min. After ﬁxation, the cells were permeabilized
using 100% coldmethanol and brieﬂy washedwith PBS. After blocking
with 1% BSA in PBS, the cells were incubated with rabbit anti-53R
serum (diluted 1:500, vol./vol., in PBS–1% BSA) at room temperature
for 1 hour. After washing, cells were incubated with FITC-conjugated
goat anti-rabbit serum (1:5000, Southern Biotechnology Associates)
and stained with 1 μg/mL Hoechst 33258 for 15 min. After washing,
glass cover slips were mounted using ProLong Gold antifade reagent
(Invitrogen) and ﬂuorescence was observed using a Nikon Eclipse 50i
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